期刊文献+

辛伐他汀对2型糖尿病合并高血压患者尿蛋白的影响 被引量:3

原文传递
导出
摘要 目的研究辛伐他汀对2型糖尿病合并高血压患者尿蛋白的影响。方法 256例2型糖尿病合并高血压,尿蛋白在30~300mg的患者随机分为辛伐他汀治疗组140例和对照组116例,治疗组给予辛伐他汀40mgqn,对照组给予安慰剂口服12周后,比较治疗前后血压、血浆超敏C反应蛋白(hsCRP)、甘油三酯(TG)、总胆固醇(TC)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)、肌酐(Cr)、肌酐清除率(Ccr)、24h尿微量白蛋白(UMA)指标的变化。结果治疗组的TG、TC、LDL、UMA、hsCRP与治疗前和对照组比较明显下降,差异有统计学意义(P<0.05),而Ccr、HDL-C显著升高,差异有统计学意义(P<0.05)。结论辛伐他汀能改善2型糖尿病合并高血压患者的尿蛋白,有助于延缓肾病进展。
出处 《中华临床医师杂志(电子版)》 2012年第3期176-177,共2页 Chinese Journal of Clinicians(Electronic Edition)
  • 相关文献

参考文献11

  • 1Go AS,Chertow CM,Fan D. Chronic kidney disease and the risks of death,cardiovascular events,and hospitalization[J].New England Journal of Medicine,2004.1296-1305.
  • 2Abdin AA,Hassanien MA,Ibrahim EA. Modulating effect of ator-vastatin on paraoxonase 1 activity in type 2 diabetic Egyptian patients with or without nephropathy[J].Journal of Diabetes and its Complications,2010.325-333.
  • 3Chade AR,Lerman A,Lerman LO. Kidney in early atherosclerosis[J].Hypertension,2005.1042-1049.
  • 4Bianchi S,Bigazzi R,Caiazza A. A controlled prospective study of the effects of atorvastatin on proteinuria and progression of kidney disease[J].American Journal of Kidney Diseases,2003.565-570.
  • 5Cheng XW,Kuzuya M,Sasaki T. Inhibition of mineralocorticoid receptor is a renoprotective effect of the 3-hydroxy-3-methylglutaryl-co-enzyme A reductase inhibitor pitavastatin[J].Journal of Hypertension,2011.542-552.
  • 6Carla Zoja,Daniela Coma,Elena Cagliardini. Adding a statin to a combination of ACE inhibitor and ARB normalizes proteinuria in experimental diabetes,which translates into full renoprotection[J].American Journal of Physiology-Renal Physiology,2010.F1203-F1211.
  • 7Muhlestein JB. Effect of antiplatelet therapy on inflammatory markers in therothrombotic patients[J].Thrombosis and Haemostasis,2010.71-82.
  • 8Knight SF,Yuan J,Roy S. Simvastatin and tempol protect against endothelial dysfunction and renal injury in a model of obesity and hypertension[J].American Journal of Physiology-Renal Physiology,2010.F86-F94,2010.
  • 9Epstein M,Campese VM. Pleiotropic effects of 3-hydroxy-3-methylglu-taryco enzyme a reductase inhibitors on renal function[J].American Journal of Kidney Diseases,2005.2-14.
  • 10Soy RC,Kastelein JJ,Arisz L. Atorvastatin and the dyslipidemi of early renalfailure[J].Atheroclerosis,2003.187-194.

同被引文献22

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部